UF researcher and OneVax CEO Dr. Mark Atkinson is honored for his preeminent contributions to the treatment and understanding of Type I diabetes. OneVax is a resident client at UF Innovate | Sid Martin Biotech.
As part of its continuing program to highlight expertise and excellence in healthcare, Expertscape.com takes pleasure in recognizing the world’s top institutions and medical specialists in the research and treatment of Type 1 Diabetes.
According to the American Diabetes Association, Type 1 Diabetes is an autoimmune disease whereby the body fails to produce the insulin needed to break down carbohydrates into blood glucose, which can then be properly metabolized at the cell level. It is estimated that about 1.25 million Americans have Type 1 Diabetes and an estimated 40,000 people will be newly diagnosed each year in the U.S.Learn more about Expertscape Ranks World’s Top Doctors and Institutions in Type 1 Diabetes.